GLP-1, released from the intestines after eating, regulates blood sugar by stimulating insulin release and reducing glucose production by the liver
In response to the arrival of oral therapies, could some manufacturers elevate long-acting injectables, e.g., with monthly or even less frequent dosing, to redefine patient convenience and re-set competitive dynamics
Importantly, the FDA label for tirzepatide includes warnings about potential pregnancy risk and contraceptive interactions
It transforms a vague complaint of "I feel anxious" into actionable clinical information
We ensure our relationship with customers doesnt just end at checkout
Why not give this to everyone and maybe not everyone, but for those who could actually use it, as opposed to having to go through this process, and theres some insurance issues with cost of those sort of things